These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15751275)

  • 21. Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.
    Coudray AM; Louvet C; Kornprobst M; Raymond E; André T; Tournigand C; Faivre S; De Gramont A; Larsen AK; Gespach C
    Int J Oncol; 2005 Aug; 27(2):553-61. PubMed ID: 16010439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of Curcuma purpurascens BI. rhizome on HT-29 colon cancer cells through mitochondrial-dependent apoptosis pathway.
    Rouhollahi E; Zorofchian Moghadamtousi S; Paydar M; Fadaeinasab M; Zahedifard M; Hajrezaie M; Ahmed Hamdi OA; Looi CY; Abdulla MA; Awang K; Mohamed Z
    BMC Complement Altern Med; 2015 Feb; 15():15. PubMed ID: 25652758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model.
    Britten CD; Hilsenbeck SG; Eckhardt SG; Marty J; Mangold G; MacDonald JR; Rowinsky EK; Von Hoff DD; Weitman S
    Cancer Res; 1999 Mar; 59(5):1049-53. PubMed ID: 10070962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.
    Chen TC; Su S; Fry D; Liebes L
    Cancer; 2003 May; 97(9 Suppl):2363-73. PubMed ID: 12712458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line.
    Inoue Y; Miki C; Watanabe H; Hiro J; Toiyama Y; Ojima E; Yanagi H; Kusunoki M
    J Gastroenterol; 2006 Dec; 41(12):1149-57. PubMed ID: 17287894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
    Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
    Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
    Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
    J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe
    Krishnan P; Rajan M; Kumari S; Sakinah S; Priya SP; Amira F; Danjuma L; Pooi Ling M; Fakurazi S; Arulselvan P; Higuchi A; Arumugam R; Alarfaj AA; Munusamy MA; Hamat RA; Benelli G; Murugan K; Kumar SS
    Sci Rep; 2017 Sep; 7(1):10962. PubMed ID: 28887536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental study of effect of epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in combination with irinotecan].
    Xu JM; Li YM; Wang Y; Zhao CH; Yuan SJ; Yang WW; Li ZQ; Han Y; Azzariti A; Paradiso A
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):578-82. PubMed ID: 17236550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides.
    Dharap SS; Qiu B; Williams GC; Sinko P; Stein S; Minko T
    J Control Release; 2003 Aug; 91(1-2):61-73. PubMed ID: 12932638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro augmentation of antitumor effect in combination with CPT-11 and CDDP for human colorectal cancer.
    Tsunoda T; Tanimura H; Hotta T; Tani M; Iwahashi M; Ishimoto K; Tanaka H; Matsuda K; Yamaue H
    J Surg Oncol; 2000 Jan; 73(1):6-11. PubMed ID: 10649271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells.
    Liu JJ; Nilsson A; Oredsson S; Badmaev V; Zhao WZ; Duan RD
    Carcinogenesis; 2002 Dec; 23(12):2087-93. PubMed ID: 12507932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
    Shinohara H; Killion JJ; Kuniyasu H; Kumar R; Fidler IJ
    Clin Cancer Res; 1998 Sep; 4(9):2053-63. PubMed ID: 9748119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of methanolic extract from silkworm droppings on proliferation and caspase activity in HT-29 human colon cancer cells.
    Hwang JH; Kim JY; Cha MR; Park HR
    J Med Food; 2007 Sep; 10(3):467-72. PubMed ID: 17887940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase.
    Andersson D; Liu JJ; Nilsson A; Duan RD
    Anticancer Res; 2003; 23(4):3317-22. PubMed ID: 12926069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursolic acid induces Bax-dependent apoptosis through the caspase-3 pathway in endometrial cancer SNG-II cells.
    Achiwa Y; Hasegawa K; Komiya T; Udagawa Y
    Oncol Rep; 2005 Jan; 13(1):51-7. PubMed ID: 15583801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromoethylindole (BEI-9) redirects NF-κB signaling induced by camptothecin and TNFα to promote cell death in colon cancer cells.
    Chowdhury R; Gales D; Valenzuela P; Miller S; Yehualaeshet T; Manne U; Francia G; Samuel T
    Apoptosis; 2017 Dec; 22(12):1553-1563. PubMed ID: 29116428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
    Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells.
    Lagadec P; Griessinger E; Nawrot MP; Fenouille N; Colosetti P; Imbert V; Mari M; Hofman P; Czerucka D; Rousseau D; Berard E; Dreano M; Peyron JF
    Br J Cancer; 2008 Jan; 98(2):335-44. PubMed ID: 18182997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.